Science AI Journal
Engineering · Research topic

Open research questions in Innovative Microfluidic and Catalytic Techniques Innovation

48 unresolved questions extracted from the limitations and future-work sections of 87 Innovative Microfluidic and Catalytic Techniques Innovation papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Segmented flow tubular reactors have been applied to precipitation of nanosized powders (reference 60), but direct comparison of segmented flow performance for solid handling versus packed bed and trickle bed approaches in heterogeneous continuous-flow catalysis has not been rigorously conducted.

    Overcoming the Achilles Heel of flow chemistry: strategies for solid handling in heterogeneous continuous-flow reactors · 2026 · DOI

  • Oscillatory flow reactors show promise for synthetic chemistry (reference 51), but the specific operating window for solid handling in oscillatory baffled reactors—including optimal frequency, amplitude, and particle size ranges—for preventing segregation and achieving uniform conversion in heterogeneous reactions remains experimentally underdefined.

    Overcoming the Achilles Heel of flow chemistry: strategies for solid handling in heterogeneous continuous-flow reactors · 2026 · DOI

  • Particle residence time distribution in helical tube devices has been studied (reference 50), but suspension flow behavior characterization specifically for metal nanoparticle catalysts in continuous-flow slurry reactors with varying particle loadings and sizes requires systematic investigation to optimize solid handling performance.

    Overcoming the Achilles Heel of flow chemistry: strategies for solid handling in heterogeneous continuous-flow reactors · 2026 · DOI

  • The sensitivity analysis for numbered-up photomicroreactor systems (reference 61) addresses gas-liquid photoredox catalysis scaling, but comparable sensitivity analyses for solid-handling heterogeneous continuous-flow reactors operating at increased throughput have not been conducted, limiting predictive scale-up capability.

    Overcoming the Achilles Heel of flow chemistry: strategies for solid handling in heterogeneous continuous-flow reactors · 2026 · DOI

  • Liquid distribution uniformity in trickle bed reactors with varying bed structures remains poorly characterized for solid handling applications. Reference 68 identifies bed structure impact on liquid distribution, but specific design criteria for achieving uniform wetting in packed bed microreactors handling heterogeneous solids during continuous-flow reactions have not been systematically established.

    Overcoming the Achilles Heel of flow chemistry: strategies for solid handling in heterogeneous continuous-flow reactors · 2026 · DOI

  • Some observations, especially those involving thermocycled droplets, are best interpreted as practical cautions rather than universal rules for all droplet PCR systems.

    An expedient, biology-laboratory-compatible method for preparing functional perfluoropolyether fluorosurfactants for droplet microfluidics · 2026 · DOI

  • A significant portion of these examples were conducted on a ≤100 g scale, while detailed reports of kilogram-scale electrosynthesis remain scarce in the pharmaceutical industry.

    Overview of Recent Scale-Ups in Organic Electrosynthesis (2000–2023) · 2024 · DOI

  • As shown in this work, RoboChem constitutes a versatile robotic platform for the self-optimization, intensification, and/or scale-up of a diverse set of photocatalytic reactions. Operated through a BO algorithm, this platform is able to explore the presented parameter space, ultimately fur- nishing customized reaction conditions at- tuned to the specific needs of each substrate. By substantially reducing the need for human intervention, RoboChem not only increases operational safety but also liberates research- ers to dedicate more time to the more creative aspects of chemistry, thereby freeing them from the drudgery of reaction optimization and in- tensification tasks. The modularity of the robotic platform is an asset of our design, and we foresee its inte- gration with different types of flow reactors and process analytical technologies in the future. Moreover, by individually optimizing reaction parameters and generating datasets that include both optimal and suboptimal conditions, intricate relationships between the targeted reaction parameters, the substrate structures, and the objective functions can be uncovered. The ability to automatically gen- erate rich datasets, obtained within a highly reproducible reactor environment, can con- tribute to the future digitization of synthetic chemistry.

    Automated self-optimization, intensification, and scale-up of photocatalysis in flow · 2024 · DOI

  • With the rapid development of droplet generation and manipulation techniques, the focus of droplet microfluidics is moving from laboratory investigations to technological applications, including the industrial production of lowerof value-added materials biomedical samples.

    Development and future of droplet microfluidics · 2024 · DOI

  • The paper employs fluorescence-based assays with optical cartridge plate readers but does not address how assay standardization protocols should account for reagent stability degradation during continuous extended operation of the integrated flow-chemistry-to-bioassay platform.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • Integration of feedback loops and automation with seamless software control across synthesis, purification, and biological assay modules has not yet been considered; no specifications exist for the communication protocols, data schemas, or latency requirements needed for true closed-loop operation of the Cyclofluidics platform.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The greatest unresolved challenge identified is developing an optimization algorithm that minimizes experiment cycles while achieving successful lead optimization; while random forest and multiparameter optimization approaches were selected, the paper does not specify how these algorithms perform across different Bcr-Abl SAR landscapes or define criteria for determining the 'known area of chemical space' required as input.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • In-flow biochemical assays for IC50 determination showed complications in ensuring consistent seamless performance; the platform switched to conventional microtiter plate-based assays but no direct comparison of IC50 values obtained from flow-based versus plate-based detection methods for Bcr-Abl kinase inhibitors has been reported to validate equivalency.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The initial 24-position reagent carousel was deemed insufficient for exploring chemical space; while the paper aspirationally targets evaluation of ~1 million compounds (requiring 300 reagents for 100×100×100 two-step combinations), no validation data exists demonstrating that larger commercial carousel systems can maintain reagent stability, compatibility, and integration reliability across extended operational cycles.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The platform was limited to two-step reaction sequences (with optional third deprotection step); integration of longer multi-step synthesis sequences with inline intermediate workup and purification for Bcr-Abl kinase inhibitor scaffold elaboration remains out of scope and requires development of automated workup protocols.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The paper identifies that ensuring compound solubility after dilution with excess aqueous-based buffer remains unresolved; specific protocols for predicting and maintaining solubility of poorly water-soluble Bcr-Abl kinase inhibitor analogs during nano-HPLC gradient delivery at low flow rates and high pressures need development.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The initial flow chemistry platform utilized custom glass chips with 80 μm channels that were abandoned in favor of 75 μm ID capillary tubing, but no systematic comparison of channel geometry effects on compound solubility, reaction efficiency, or assay performance in the Bcr-Abl kinase inhibitor synthesis has been documented.

    Flow Chemistry in Medicinal Chemistry: Applications to <scp>Bcr</scp> ‐ <scp>Abl</scp> Kinase Inhibitors · 2022 · DOI

  • The paper states that fully integrated design-synthesize-test-purify cycles can combine algorithmic predictions with biological screening in automated platforms, but does not specify the integration requirements between flow chemistry synthesis modules and downstream purification/characterization modules, nor provides data on throughput compatibility between synthesis and purification rates in integrated systems.

    Flow Chemistry in Drug Discovery: Challenges and Opportunities · 2021 · DOI

  • While the paper mentions that microfluidic cell-chips can execute 1,500 chemical combinations per day with real-time analysis, there is no investigation of how reaction scaling from microfluidic chip conditions to preparative flow reactor scales affects yield, selectivity, and consistency when using the same AI-optimized parameters.

    Flow Chemistry in Drug Discovery: Challenges and Opportunities · 2021 · DOI

  • The paper describes integration of AI algorithms with continuous flow platforms for synthetic route selection and parameter optimization, but does not specify what types of chemical reaction databases are required, how complete these databases must be, or validation metrics for AI-predicted synthetic routes when translated from small-scale microfluidic screening to larger manufacturing scale.

    Flow Chemistry in Drug Discovery: Challenges and Opportunities · 2021 · DOI

  • The paper discusses solubility limitations in flow chemistry compared to parallel batch approaches (which can perform diverse chemistries regardless of solvent mixture solubility), but provides no concrete data on the specific solubility thresholds that prevent flow chemistry applicability or systematic guidelines for predicting which reaction classes will face solubility constraints in continuous flow reactors.

    Flow Chemistry in Drug Discovery: Challenges and Opportunities · 2021 · DOI

  • The paper identifies that analytical analysis of automated high-throughput experimentation (HTE) reactions is relatively slow and limits the benefits of the technology. While coupling with mass spectrometry (MS) is mentioned as a solution, there is no detailed investigation of the specific throughput bottlenecks in automated reaction analysis or systematic comparison of different analytical integration strategies (inline vs. offline MS, real-time vs. batch analysis) for flow chemistry platforms.

    Flow Chemistry in Drug Discovery: Challenges and Opportunities · 2021 · DOI

  • The three-step functionalization–Boc deprotection–functionalization sequence (Scheme 21) generates >180 mg of final material without intermediate purifications, but no data are provided on whether this inline processing strategy introduces detectable byproduct accumulation, how product purity compares to batch-purified analogs, or what impurity thresholds trigger need for inline purification between steps.

    Flow Chemistry as a Drug Discovery Tool: A Medicinal Chemistry Perspective · 2018 · DOI

  • The diazomethane tube-in-tube reactor successfully synthesizes arylcyclopropyl boronates at scales up to 190 mg/h, but the paper does not evaluate whether this throughput and product quality are maintainable during extended production runs (>8 hours), nor does it address how reaction efficiency varies with changes in THF purity, moisture content, or diazomethane solution age.

    Flow Chemistry as a Drug Discovery Tool: A Medicinal Chemistry Perspective · 2018 · DOI

  • The MACOS microwave-heated thin-film catalysis system (Scheme 22) achieves temperatures exceeding 900°C on copper or gold-coated capillaries for multicomponent propargyl amine synthesis, but the paper does not specify the thermal stability limits of the capillary coatings, their reusability/lifetime, temperature uniformity across the reaction zone, or applicability to other metal films (e.g., platinum, nickel).

    Flow Chemistry as a Drug Discovery Tool: A Medicinal Chemistry Perspective · 2018 · DOI

Most-cited papers in Innovative Microfluidic and Catalytic Techniques Innovation

Most recent work

Find a gap in your own Innovative Microfluidic and Catalytic Techniques Innovation sub-topic

This page shows what the Innovative Microfluidic and Catalytic Techniques Innovation literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Engineering

Traffic and Road Safety
143 open questions
Spatial Cognition and Navigation
95 open questions
Smart Cities and Technologies
89 open questions
BIM and Construction Integration
87 open questions
Design Education and Practice
86 open questions
Engineering Education and Curriculum Development
82 open questions
Digital Transformation in Industry
81 open questions
Perovskite Materials and Applications
78 open questions
48 open questions have been extracted from the limitations and future-work passages of 87 Innovative Microfluidic and Catalytic Techniques Innovation papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.